Korean Drug Co. Ltd (014570) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.024x

Based on the latest financial reports, Korean Drug Co. Ltd (014570) has a cash flow conversion efficiency ratio of 0.024x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.90 Billion ≈ $1.29 Million USD) by net assets (₩78.82 Billion ≈ $53.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Korean Drug Co. Ltd worth for the company's overall valuation and market capitalisation.

Korean Drug Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Korean Drug Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Korean Drug Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Korean Drug Co. Ltd ranked by their cash flow conversion efficiency. Explore Korean Drug Co. Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Madison Pacific Properties Inc. TO:MPC	0.019x
ACCESS Newswire Inc. NYSE MKT:ACCS	-0.019x
Transtema Group AB ST:TRANS	-0.006x
CU Medical Systems Inc KQ:115480	-0.030x
Victory New Materials Ltd Co TW:1340	0.004x
Finebesteel KO:133820	0.013x
Nable Communications Inc KQ:153460	-0.017x
Hoftex Group AG MU:NBH	0.032x

Annual Cash Flow Conversion Efficiency for Korean Drug Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Korean Drug Co. Ltd from 2014 to 2025. View Korean Drug Co. Ltd stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩83.07 Billion ≈ $56.30 Million	₩13.11 Billion ≈ $8.88 Million	0.158x	+153.18%
2024-12-31	₩78.11 Billion ≈ $52.93 Million	₩4.87 Billion ≈ $3.30 Million	0.062x	+340.45%
2023-12-31	₩77.09 Billion ≈ $52.24 Million	₩-2.00 Billion ≈ $-1.35 Million	-0.026x	-137.14%
2022-12-31	₩84.71 Billion ≈ $57.41 Million	₩5.91 Billion ≈ $4.01 Million	0.070x	-39.22%
2021-12-31	₩76.69 Billion ≈ $51.97 Million	₩8.81 Billion ≈ $5.97 Million	0.115x	-34.00%
2020-12-31	₩70.87 Billion ≈ $48.03 Million	₩12.33 Billion ≈ $8.36 Million	0.174x	+82.29%
2019-12-31	₩65.05 Billion ≈ $44.08 Million	₩6.21 Billion ≈ $4.21 Million	0.095x	+3.56%
2018-12-31	₩62.80 Billion ≈ $42.56 Million	₩5.79 Billion ≈ $3.92 Million	0.092x	+1074.16%
2017-12-31	₩56.97 Billion ≈ $38.61 Million	₩447.20 Million ≈ $303.06K	0.008x	-89.37%
2016-12-31	₩53.66 Billion ≈ $36.37 Million	₩3.96 Billion ≈ $2.69 Million	0.074x	-40.18%
2015-12-31	₩49.68 Billion ≈ $33.67 Million	₩6.13 Billion ≈ $4.16 Million	0.123x	+34.95%
2014-12-31	₩48.79 Billion ≈ $33.06 Million	₩4.46 Billion ≈ $3.02 Million	0.091x	--

About Korean Drug Co. Ltd

KQ:014570 Korea Drug Manufacturers - General

Market Cap

$25.05 Million

₩36.97 Billion KRW

Market Cap Rank

#24463 Global

#1747 in Korea

Share Price

₩3415.00

Change (1 day)

+0.44%

52-Week Range

₩3120.00 - ₩4600.00

All Time High

₩13030.58